Correction to: Chemotherapy: a double‑edged sword in cancer treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/s00262-021-03013-3)
Publication date
2022-03
Authors
Behranvand, Nafiseh
Nasri, Farzad
Zolfaghari Emameh, Reza
Khani, Pouria
Hosseini, Asieh
Garssen, Johan
Falak, Reza
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
The original version of this article unfortunately contained a mistake. Third author's name was incorrect. First name of this author was missed and an extra "m" is also inserted in his last name. The first name of this author is "Reza" and his last name is "Zolfaghari Emameh" and ORCID # is: 0000-0002-3253-7844 The original article has been corrected.
Keywords
Taverne, Immunology and Allergy, Immunology, Oncology, Cancer Research, SDG 3 - Good Health and Well-being
Citation
Behranvand, N, Nasri, F, Zolfaghari Emameh, R, Khani, P, Hosseini, A, Garssen, J & Falak, R 2022, 'Correction to : Chemotherapy: a double‑edged sword in cancer treatment (Cancer Immunology, Immunotherapy, (2022), 71, 3, (507-526), 10.1007/s00262-021-03013-3)', Cancer Immunology, Immunotherapy, vol. 71, no. 3, pp. 527. https://doi.org/10.1007/s00262-021-03034-y